GHK-Cu and Argireline are both topical cosmetic peptides, but they target different signs of aging. GHK-Cu is a copper peptide that supports skin remodeling and collagen-related pathways; Argireline (acetyl hexapeptide) is a SNARE-targeting peptide marketed for softening expression lines, sometimes called "topical Botox." Both are cosmetic ingredients with modest, gradual effects.
At a glance
| GHK-Cu | Argireline | |
|---|---|---|
| Type | Copper-binding tripeptide | Acetyl hexapeptide (SNARE-targeting) |
| Targets | Collagen, skin remodeling, firmness | Expression/movement lines |
| Nickname | Copper peptide | 'Topical Botox' |
| Regulation | Cosmetic ingredient | Cosmetic ingredient |
| Effect size | Modest, gradual | Modest, gradual |
| Route | Topical | Topical |
The bottom line
Bottom line: They tackle different problems and are often used together. GHK-Cu works on overall skin quality, firmness, and remodeling; Argireline targets the fine lines caused by repeated facial movement. Both are cosmetics with modest, cumulative effects — not drugs, and not a replacement for medical treatments like retinoids.
Frequently asked questions
What's the difference between GHK-Cu and Argireline?
GHK-Cu is a copper peptide that supports collagen and skin remodeling for overall firmness, while Argireline is a SNARE-targeting peptide aimed at softening expression lines. They address different signs of aging.
Is Argireline really like Botox?
It's marketed as 'topical Botox' because it targets the muscle-signaling (SNARE) pathway, but as a topical cosmetic its effect is far milder and more gradual than injected botulinum toxin.
Can you use them together?
They are often combined in skincare because they target different mechanisms — overall skin quality versus expression lines. Both are cosmetics with modest, cumulative effects.
References
Combined peer-reviewed sources from both peptide guides. Inclusion is not endorsement.
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018. Peer-reviewed study
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015. Peer-reviewed study
- Pickart L, Vasquez-Soltero JM, Margolina A. The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging. Oxid Med Cell Longev. 2012. Peer-reviewed study
- Ogórek K, Nowak K, Wadych E, et al. Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?. Molecules. 2025. Peer-reviewed study
- Dymek M, Olechowska K, Hąc-Wydro K, et al. Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application. Pharmaceutics. 2023. Peer-reviewed study
- Sahu R, Yadav S, Gunturu KC, et al. Phenothiazine-Based Cu(II)-Selective Fluorescent Sensor: GHK-Cu Sensing Applications. J Org Chem. 2023. Peer-reviewed study
- Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002. Peer-reviewed study
- Lim SH, Sun Y, Madanagopal TT, et al. Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification. Sci Rep. 2018. Peer-reviewed study
- Velazco de Maldonado GJ, Suárez-Vega DV, Miller-Kobisher B, et al. Polydioxanone Bioactive Sutures-Acetyl Hexapeptide-8 (Argireline): An Intelligent System for Controlled Release in Facial Harmonization. J Cutan Aesthet Surg. 2023. Peer-reviewed study
- Wang Y, Wang M, Xiao S, et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013. Peer-reviewed study
- Chen CF, Liu J, Wang SS, et al. Mycobacterium abscessus infection after facial injection of argireline: A case report. World J Clin Cases. 2021. Peer-reviewed study
- Kluczyk A, Ludwiczak J, Modzel M, et al. Argireline: Needle-Free Botox as Analytical Challenge. Chem Biodivers. 2021. Peer-reviewed study